Is Mammotome Excision Feasible for Benign Breast Mass Bigger than 3 cm in Greatest Dimension?.
- Author:
Hai Lin PARK
1
;
Jin Young KWAK
;
Haekyong JUNG
;
Seung Hee LEE
;
Jeong Yun SHIM
;
Ji Young KIM
;
Kyung Sik LEE
Author Information
1. Department of Surgery, Kangnam Cha Hospital, Pochon Cha University College of Medicine, Seoul, Korea. PHL1@cha.ac.kr
- Publication Type:Original Article
- Keywords:
Mammotome excision;
Big benign breast tumor
- MeSH:
Abscess;
Breast*;
Cicatrix;
Fibroadenoma;
Follow-Up Studies;
Hand;
Hemorrhage;
Humans;
Ultrasonography
- From:Journal of the Korean Surgical Society
2006;70(1):25-29
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The aim of this study was to evaluate that a surgeon can safely remove all sonographic evidence of masses in the breast grater than 3.0 cm in greatest dimension using the 8 g hand held Mammotome (MT). METHODS: From Jan. 2003 to Mar. 2005, a total of 1,368 US-guided MT excision were performed in 1,112 patients at Kangnam Cha hospital. Of these 1,368 lesions 28 lesions with BI-RADS category 3 features by ultrasonography were included in this study. Ultrasonographic follow-up were performed on 3~6 months later to assess residual tissue and scarring. RESULTS: Mean patient age was 32.0 years (range 20~55 years). The average size of lesion was 3.5 cm (SD+-0.43 cm). All of the lesions were palpable and all of the specimens were benign. Most common pathologic features were fibroadenoma (75.0%) and breast abscess (14.3%). Mean time required to perform mammotome procedures was 12.2+/-8.2 minutes and mean number of cores removed were 35.1+/-30.2 pieces. No bleeding or infections occurred postoperatively and most complications were mild and anticipated. CONCLUSION: This study demonstrates that percutaneous removal of big breast benign mass above 3 cm in diameter using The MT system is feasible, effective and safe method for the therapeutic management with minimal morbidity without any additional procedures.
